Yan Dora Zhang

Dr. Yan Dora Zhang

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 July 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
YZYan Dora Zhang
Yan Dora Zhang
AHAmber N. Hurson
Amber N. Hurson
HZHaoyu Zhang
Haoyu Zhang
PCParichoy Pal Choudhury
Parichoy Pal Choudhury
DEDouglas F. Easton
Douglas F. Easton
MGMontserrat Garcia-Closas
Montserrat Garcia-Closas
Genome-wide association studies (GWAS) have led to the identification of hundreds of susceptibility loci across cancers, but the impact of further studies remains uncertain. Here we analyse summary-level data from GWAS of European ancestry across fourteen cancer sites to estimate the number of common susceptibility variants (polygenicity) and underlying effect-size distribution. All cancers show a high degree of polygenicity, involving at a minimum of thousands of loci. We project that sample sizes required to explain 80% of GWAS heritability vary from 60,000 cases for testicular to over 1,000,000 cases for lung cancer. The maximum relative risk achievable for subjects at the 99th risk percentile of underlying polygenic risk scores (PRS), compared to average risk, ranges from 12 for testicular to 2.5 for ovarian cancer. We show that PRS have potential for risk stratification for cancers of breast, colon and prostate, but less so for others because of modest heritability and lower incidence.

12 November 2020 in Journal of the American Statistical Association
Verified
Journal Article
Closed access
YZYan Dora Zhang
Yan Dora Zhang
BNBrian P. Naughton
Brian P. Naughton
HBHoward D. Bondell
Howard D. Bondell
BRBrian J. Reich
Brian J. Reich
Prior distributions for high-dimensional linear regression require specifying a joint distribution for the unobserved regression coefficients, which is inherently difficult. We instead propose a new class of shrinkage priors for linear regression via specifying a prior first on the model fit, in particular, the coefficient of determination, and then distributing through to the coefficients in a novel way. The proposed method compares favorably to previous approaches in terms of both concentration around the origin and tail behavior, which leads to improved performance both in posterior contraction and in empirical performance. The limiting behavior of the proposed prior is 1/x , both around the origin and in the tails. This behavior is optimal in the sense that it simultaneously lies on the boundary of being an improper prior both in the tails and around the origin. None of the existing shrinkage priors obtain this behavior in both regions simultaneously. We also demonstrate that our proposed prior leads to the same near-minimax posterior contraction rate as the spike-and-slab prior. Supplementary materials for this article are available online.

19 August 2022 in Frontiers in Genetics
Verified
Journal Article
Open access
PTPeixin Tian
Peixin Tian
TCTsai Hor Chan
Tsai Hor Chan
YWYong-Fei Wang
Yong-Fei Wang
WYWanling Yang
Wanling Yang
GYGuosheng Yin
Guosheng Yin
YZYan Dora Zhang
Yan Dora Zhang
Polygenic risk scores (PRS) leverage the genetic contribution of an individual’s genotype to a complex trait by estimating disease risk. Traditional PRS prediction methods are predominantly for the European population. The accuracy of PRS prediction in non-European populations is diminished due to much smaller sample size of genome-wide association studies (GWAS). In this article, we introduced a novel method to construct PRS for non-European populations, abbreviated as TL-Multi, by conducting a transfer learning framework to learn useful knowledge from the European population to correct the bias for non-European populations. We considered non-European GWAS data as the target data and European GWAS data as the informative auxiliary data. TL-Multi borrows useful information from the auxiliary data to improve the learning accuracy of the target data while preserving the efficiency and accuracy. To demonstrate the practical applicability of the proposed method, we applied TL-Multi to predict the risk of systemic lupus erythematosus (SLE) in the Asian population and the risk of asthma in the Indian population by borrowing information from the European population. TL-Multi achieved better prediction accuracy than the competing methods, including Lassosum and meta-analysis in both simulations and real applications.

28 February 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
ZLZipeng Liu
Zipeng Liu
YQYiming Qin
Yiming Qin
TWTian Wu
Tian Wu
JTJustin D. Tubbs
Justin D. Tubbs
Larry BaumLarry Baum
Larry Baum
PSPak Sham
Pak Sham
Mendelian randomization using GWAS summary statistics has become a popular method to infer causal relationships across complex diseases. However, the widespread pleiotropy observed in GWAS has made the selection of valid instrumental variables problematic, leading to possible violations of Mendelian randomization assumptions and thus potentially invalid inferences concerning causation. Furthermore, current MR methods can examine causation in only one direction, so that two separate analyses are required for bi-directional analysis. In this study, we propose a ststistical framework, MRCI (Mixture model Reciprocal Causation Inference), to estimate reciprocal causation between two phenotypes simultaneously using the genome-scale summary statistics of the two phenotypes and reference linkage disequilibrium information. Simulation studies, including strong correlated pleiotropy, showed that MRCI obtained nearly unbiased estimates of causation in both directions, and correct Type I error rates under the null hypothesis. In applications to real GWAS data, MRCI detected significant bi-directional and uni-directional causal influences between common diseases and putative risk factors.

27 March 2020 in Genetic Epidemiology
Verified
Journal Article
Closed access
PDF file
JTJustin D. Tubbs
Justin D. Tubbs
YZYan Dora Zhang
Yan Dora Zhang
PSPak Sham
Pak Sham

28 February 2022 in BMJ Global Health
Verified
Journal Article
Open access
PDF file
DLDaoyuan Lai
Daoyuan Lai
YCYuxi Cai
Yuxi Cai
TCTsai Hor Chan
Tsai Hor Chan
DGDailin Gan
Dailin Gan
AHAmber N Hurson
Amber N Hurson
YZYan Dora Zhang
Yan Dora Zhang
It has been nearly 2 years since the first case of COVID-19 was reported. Governments worldwide have introduced numerous non-pharmaceutical interventions (NPIs) to combat this disease. Many of these NPIs were designed in response to initial outbreaks but are unsustainable in the long term. Governments are exploring how to adjust their current NPIs to resume normal activities while effectively protecting their population. As one of the most controversial NPIs, the implementation of travel restrictions varies across regions. Some governments have abandoned their previous travel restrictions because of the induced costs to society and on the economy. Other areas, including Hong Kong (Special Administrative Region of China) and Singapore, continue employing these NPIs as a long-term disease prevention tactic. However, the multidimensional impacts of travel restrictions require careful consideration of how to apply restrictions more appropriately. We have proposed an adapted framework to examine Hong Kong and Singapore’s travel restrictions. We aimed to study these two regions’ experiences in balancing disease control efforts with easing the burden on lives and livelihoods. Based on the experiences of Hong Kong and Singapore, we have outlined six policy recommendations to serve as the cornerstone for future research and policy practices.